Vertaling van "established products " (Nederlands → Frans) :

TERMINOLOGIE

product dat aescine bevat
produit contenant de l'aescine

product dat balsalazide bevat
produit contenant du balsalazide

product dat bacitracine bevat
produit contenant de la bacitracine

product dat barbituraat bevat
produit contenant du barbiturique

product dat basiliximab bevat
produit contenant du basiliximab

product dat baclofen bevat
produit contenant du baclofène

product dat auranofine bevat
produit contenant de l'auranofine

product dat auranofine in orale vorm bevat
produit contenant de l'auranofine sous forme orale

product dat enkel auranofine in orale vorm bevat
produit contenant seulement de l'auranofine sous forme orale

product dat baricitinib bevat
produit contenant du baricitinib

IN-CONTEXT TRANSLATIONS

Law of 20 July 2006 on the establishment and functioning of the Federal Agency for Medicines and Health Products Royal decrees of 25 February 2007 on the composition and working method of the committees of the Federal Agency for Medicines and Health Products Royal decree of 20 December 2007 determining the date of establishment of the Scientific Committee, namely 1 February 2008 Royal decree of 28 January 2008 on the concrete composition of the Consultative Committee Ministerial decree of 11 January 2007 on the composition and appointment of the members of the executive board of the Federal Agency for Medicines and Health Products
Law of 20 July 2006 on the establishment and functioning of the Federal Agency for Medicines and Health Products Royal decrees of 25 February 2007 on the composition and working method of the committees of the Federal Agency for Medicines and Health Products Royal decree of 20 December 2007 determining the date of establishment of the Scientific Committee, namely 1 February 2008 Royal decree of 28 January 2008 on the concrete composition of the Consultative Committee Ministerial decree of 11 January 2007 on the composition and appointment of the members of the executive board of the Federal Agency for Medicines and Health Products

Thus the FAHMP inspectors in the Production & Distribution department have a duty to control the relevant industry (medicines and health products), the blood establishments, the cell and tissue banks, the wholesale trade of medicines and health products, the retail and hospital pharmacies and the stocks of medicines at the veterinarians.
Thus the FAHMP inspectors in the Production & Distribution department have a duty to control the relevant industry (medicines and health products), the blood establishments, the cell and tissue banks, the wholesale trade of medicines and health products, the retail and hospital pharmacies and the stocks of medicines at the veterinarians.

Exelon/Exelon Patch 244 251 -3 0 Comtan/Stalevo 152 141 8 9 Extavia 26 14 86 102 Other 111 108 3 6 Total strategic franchise products 931 849 10 13 Established medicines 137 145 -6 -6 Total Neuroscience and Ophthalmics products 1 068 994 7 10
Exelon/Exelon Patch 244 251 -3 0 Comtan/Stalevo 152 141 8 9 Extavia 26 14 86 102 Autres 111 108 3 6 Total produits stratégiques 931 849 10 13 Médicaments établis 137 145 -6 -6 Total produits neurologiques et ophtalmologiques 1 068 994 7 10

Exforge 222 171 30 33 Tekturna/Rasilez 113 83 36 42 Subtotal 1 818 1 718 6 7 Galvus 101 50 102 114 Lotrel 80 75 7 4 Total strategic franchise products 1 999 1 843 8 10 Established medicines (including Lescol) 264 320 -18 -17 Total Cardiovascular and Metabolism products 2 263 2 163 5 6
Exforge 222 171 30 33 Rasilez/Tekturna 113 83 36 42 Sous-total 1 818 1 718 6 7 Galvus 101 50 102 114 Lotrel 80 75 7 4 Total produits stratégiques 1 999 1 843 8 10 Médicaments établis (Lescol inclus) 264 320 -18 -17 Total produits cardiovasculaires et métaboliques 2 263 2 163 5 6

TOBI 70 76 -8 -5 Onbrez 8 0 nm nm Other -2 nm nm Total strategic franchise products 175 152 15 20 Established medicines 37 40 -8 -4 Total Respiratory products 212 192 10 15
TOBI 70 76 -8 -5 Onbrez 8 0 ns ns Autres -2 ns ns Total produits stratégiques 175 152 15 20 Médicaments établis 37 40 -8 -4 Total produits Pneumologie 212 192 10 15

Unit I Unit I is responsible for the tasks of the secretariat of the commission for the establishment of retail pharmacies, of the secretariat of the commission for the recognition of pharmacists-clinical biologists, of the retail pharmacies registry and plays an important role in the problems of products in the “grey area” (these are “borderline” products whose exact status has to be determined: is it a medicine or not?).
Unit I Unit I is responsible for the tasks of the secretariat of the commission for the establishment of retail pharmacies, of the secretariat of the commission for the recognition of pharmacists-clinical biologists, of the retail pharmacies registry and plays an important role in the problems of products in the “grey area” (these are “borderline” products whose exact status has to be determined: is it a medicine or not?).

The FAMHP was established by law on 20 July 2006 and as from 1 January 2007 completely took over the role and fields of competency of the Directorate-General for Medicinal Products (DG Medicinal Products) that was a part of the Federal Public Service (FPS) Public Health, Food Chain Security and Environment.
The FAMHP was established by law on 20 July 2006 and as from 1 January 2007 completely took over the role and fields of competency of the Directorate-General for Medicinal Products (DG Medicinal Products) that was a part of the Federal Public Service (FPS) Public Health, Food Chain Security and Environment.

Herbal medicinal products In line with the provisions of the royal decree of 14 December 2006, three procedures are used for the issue of the MA or registration for herbal medicinal products: the full procedure, the “Well Established Use” procedure and a third specific procedure for traditional herbal medicines as stipulated in article 43 of the royal decree.
Herbal medicinal products In line with the provisions of the royal decree of 14 December 2006, three procedures are used for the issue of the MA or registration for herbal medicinal products: the full procedure, the “Well Established Use” procedure and a third specific procedure for traditional herbal medicines as stipulated in article 43 of the royal decree.

In addition to the daily activities (inspections, granting of licences/authorisations/certificates, RAS) the Production & Distribution Department also focused efforts in 2008 on gradually solving the backlog of Dutch language establishment applications and transfer applications for retail pharmacies. Additionally, the backlog in respect of raw materials used by retail pharmacies was also tackled.
In addition to the daily activities (inspections, granting of licences/authorisations/certificates, RAS) the Production & Distribution Department also focused efforts in 2008 on gradually solving the backlog of Dutch language establishment applications and transfer applications for retail pharmacies. Additionally, the backlog in respect of raw materials used by retail pharmacies was also tackled.

However, the FAMHP also intends to be an effective public service and a fully fledged partner to the numerous players in the medicines and health product fields, all of whom supported the establishment of the Agency.
However, the FAMHP also intends to be an effective public service and a fully fledged partner to the numerous players in the medicines and health product fields, all of whom supported the establishment of the Agency.